Practical issues and challenges in the diagnosis and treatment of pulmonary sarcoidosis

Drugs

Volumn 67, Issue 1, 2007, Pages 17-26

  Jindal, Surinder K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CHLORAMBUCIL; CHLOROQUINE; CORTICOSTEROID; CORTICOTROPIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; FOLIC ACID; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; INFLIXIMAB; ISONIAZID; LEFLUNOMIDE; METHOTREXATE; PENTOXIFYLLINE; PREDNISOLONE; PREDNISONE; RIFAMPICIN; THALIDOMIDE;

ASPERMIA; BLOOD ANALYSIS; BLOOD PRESSURE; CANCER RISK; CATARACT; CHEMICAL ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG DOSE REDUCTION; EARLY MENOPAUSE; EYE TOXICITY; FLUID RETENTION; FRACTURE; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; GONAD DYSFUNCTION; GRANULOMATOSIS; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; LEUKOPENIA; LIVER TOXICITY; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG TOXICITY; META ANALYSIS; MONOTHERAPY; MUCOSAL ULCER; NAUSEA AND VOMITING; OSTEOPOROSIS; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SARCOIDOSIS; SEMEN ABNORMALITY; SIDE EFFECT; SKIN MANIFESTATION; SPUTUM ANALYSIS; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TERATOGENICITY; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS; ULCER; ULTRASOUND; WEIGHT GAIN; X RAY;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; SARCOIDOSIS, PULMONARY;

EID: 33846232319     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200767010-00003     Document Type: Review

References (51)

1. James DG. Sarcoidosis 2001. Postgrad Med J 2001; 77: 177-80
2. Hosoda Y, Sasagawa S, Yamaguchi T. Sarcoidosis and tuberculosis: epidemiological similarities and dissimilarities: a review of a series of studies in a Japanese work population (1941-1996) and the general population (1959-1984). Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 85-93
3. Jindal SK, Gupta D, Aggarwal AN. Sarcoidosis in India: practical issues and difficulties in diagnosis and management. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 176-84
4. Sharma SK, Mohan A. Sarcoidosis: global scenario & Indian perspective. Indian J Med Res 2002; 116: 221-47
5. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-55
6. Soskel NT, Sharma OP. Pleural involvement in sarcoidosis. Curr Opin Pulm Med 2000; 6: 455-68
7. Loddenkemper R, Kloppenborg A, Schoenfeld N, et al. Clinical findings in 715 patients with newly detected pulmonary sarcoidosis: results of a cooperative study in former West Germany and Switzerland. WATL Study Group. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 178-82
8. James DG, Neville E, Siltzbach LE, et al. A worldwide review of sarcoidosis. Ann N Y Acad Sci 1976; 278: 321-34
9. Hutchinson J. Case of livid papillary psoriasis. In: Illustrations of clinical surgery. Vol. 1. London: J&A Churchill, 1877: 42-3
10. Sharma OP. Cutaneous sarcoidosis: clinical features and management. Chest 1972; 61: 320-5
11. Usui Y, Kaiser ED, See RF, et al. Update of ocular manifestations in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 167-75
12. Sharma O, Kadakia J, Sharma O. Gastrointestinal sarcoidosis. Semin Respir Med 1992; 13: 442-9
13. White ES, Lynch III JP. Sarcoidosis involving multiple systems: diagnostic and therapeutic challenges. Chest 2001; 119: 1593-7
14. Stern BJ. Neurological complications of sarcoidosis. Curr Opin Neurol 2004; 17: 311-6
15. Gullapalli D, Phillips II LH. Neurologic manifestations of sarcoidosis. Neurol Clin 2002; 20: 59-83
16. Scadding JG. Skin reaction of delayed type. Acta Med Scand 1965; 425: 191-4
17. James DG, Nevile E, Walker A. Immunology of sarcoidosis. Am J Med 1975; 59: 388-94
18. Gupta D, Chetty M, Kumar N, et al. Anergy to tuberculin in sarcoidosis is not influenced by high prevalence of tuberculin sensitivity in the population. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 40-5
19. Winterbauer RH, Belic N, Moores KD. A clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 1973; 79: 65-71
20. Andreu J, Mauleon S, Pallisa E, et al. Miliary lung disease revisited. Curr Probl Diagn Radiol 2002; 31: 189-97
21. Koyama T, Ueda H, Togashi K, et al. Radiologic manifestations of sarcoidosis in various organs. Radiographics 2004; 24: 87-104
22. Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis: an approach to determine the optimal number of biopsies. Am Rev Respir Dis 1980; 122: 721-4
23. Jindal SK, Gupta D, Aggarwal AN. Sarcoidosis in developing countries. Curr Opin Pulm Med 2000; 6: 448-54
24. Gupta D, Mahendran C, Aggarwal AN, et al. Endobronchial vis a vis transbronchial involvement on fiberoptic bronchoscopy in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 91-2
25. Torrington KG, Shorr AF, Parker JW. Endobronchial disease and racial differences in pulmonary sarcoidosis. Chest 1997; 111: 619-22
26. Chevalet P, Clement R, Rodat O, et al. Sarcoidosis diagnosed in elderly subjects: retrospective study of 30 cases. Chest 2004; 126: 1423-30
27. Gaede KI, Mamat U, Muller-Quernheim J. Differential gene expression pattern in alveolar macrophages of patients with sarcoidosis and tuberculosis. J Mol Med 2004; 82: 206-10
28. Costabel U, Guzman J, Drent M. Diagnostic approach to sarcoidosis. Eur Res Mon 2005; 32: 259-64
29. Ziegenhagen MW, Rothe ME, Schlaak M, et al. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003; 21: 407-13
30. Lebtahi R, Crestani B, Belmatoug N, et al. Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. J Nucl Med 2001; 42: 21-6
31. Bradivik I, Wollmer P, Blom-Bulow B, et al. Lung mechanics and gas exchange in steroid treated pulmonary sarcoidosis: a seven year follow up. Sarcoidosis 1991; 8: 105-14
32. Gupta D, Jorapur V, Bambery P, et al. Pulmonary sarcoidosis: spirometric correlation with transbronchial biopsy. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 77-80
33. Siltzbach LE, Posner A, Medine MM. Cortisone therapy in sarcoidosis. JAMA 1951; 147: 927-9
34. Gibson GJ. Sarcoidosis: old and new treatments (editorial). Thorax 2001; 56: 336-9
35. Fazzi P. Pharmacotherapeutic management of pulmonary sarcoidosis. Am J Respir Med 2003; 2: 311-20
36. Baughman RP, Lower EE. Therapy for sarcoidosis. Eur Respir Mon 2005; 32: 301-15
37. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996; 51: 238-47
38. Paramothayan S, Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev 2005; (2): CD001114
39. Pietinalho A, Tukiainen P, Haahtela T, et al. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group. Chest 1999; 116: 424-31
40. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995; 155: 846-51
41. Muller-Quernheim J, Kienast K, Held M, et al. Treatment of chronic sarcoidosis with an azathiprine/prednisolone regimen. Eur Respir J 1999; 14: 1000-1
42. Doty JD, Mazur JE, Judson MA. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 2003; 124: 2023-6
43. Baughman RP, Lower EE. Leflunomide for chronic sarcoidosis. Sacoidosis Vasc Diffuse Lung Dis 2004; 21: 43-8
44. Hallak J, Hendin BN, Thomas AJ, et al. Investigation of fertilizing capacity of cryopreserved spermatozoa from patients with cancer. J Urol 1998; 159: 1217-9
45. Ranganathan P, Mahran AM, Hallak J, et al. Sperm cryopreservation for men with nonmalignant systemic diseases: a descriptive study. J Andrology 2002; 23: 71-5
46. Mattle V, Behringer K, Engert A, et al. Female fertility after cytotoxic therapy -protection of ovarian function during chemotherapy of malignant and nonmalignant diseases. Eur J Hematol Suppl 2005; 66: 77-82
47. Sonmezer M, Shamonki MI, Oktay K. Ovarian tissue cryopreservation: benefits and risks. Cell Tissue Res 2005; 322: 125-32
48. Jones SK. Ocular toxicity and hydroxychloroquine: guidelines for screening. Br J Dermatol 1999; 140: 3-7
49. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 2005; 127: 1064-71
50. Reynolds HY. Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease. Lung 2002; 180: 281-99
51. Sharma OP. Pulmonary sarcoidosis: management. J Postgrad Med 2002; 48: 135-41